TheraDoc®, the leading provider of clinical decision support technology in healthcare, today announced that it has started beta testing of a new computerized patient surveillance tool that will help hospitals monitor and manage screening programs for multidrug-resistant organisms (MDROs), such as methicillin-resistant Staphylococcus aureus, or MRSA, which every year kills more people in the United States than AIDS.
The MDRO Compliance Manager, designed for use with TheraDoc’s Infection Control Assistant® and its Expert System Platform® core technology, was created to help hospitals boost compliance with screening protocols by quickly identifying patients who should be tested and those who need to be isolated in order to reduce the spread of MRSA and other drug-resistant organisms to other patients, staff, and visitors.
The beta testing coincides with October’s designation as World MRSA Awareness Month to increase knowledge about this serious patient safety threat. MRSA, a type of staph infection that is difficult to treat because it is resistant to many antibiotics, can cause serious problems including boils, septic wounds, heart-valve problems, toxic shock syndrome, and even death.
According to Stanley Pestotnik, M.S., R.Ph., president and chief executive officer of TheraDoc, the MDRO Compliance Manager reflects the company’s leadership role in providing real-time clinical information that positively impacts the quality and safety of patient care. “This clinical tool will help hospitals efficiently and cost-effectively manage their screening programs for MRSA and other drug-resistant organisms,” Pestotnik said.
“It’s very flexible, and once configured to match a hospital’s specific screening protocol, the tool seamlessly tracks compliance rates regarding patient screening and flags patients in need of screening tests,” he said. “Infection preventionists no longer have to spend hours manually reviewing vast amount of data. Reports can be generated at the click of a button, proving real-time, actionable information.”